Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Sep;70(3):466–473. doi: 10.1038/bjc.1994.329

Integrin expression and ability to adhere to extracellular matrix proteins and endothelial cells in human lung cancer lines.

M Hirasawa 1, N Shijubo 1, T Uede 1, S Abe 1
PMCID: PMC2033372  PMID: 8080732

Abstract

We examined the integrin expression in 19 human lung cancer cell lines with monoclonal antibodies to the integrin subunits alpha 1, alpha 2, alpha 3, alpha 4, alpha 5, alpha 6, beta 1, beta 2, and beta 4. We measured their ability to adhere to the extracellular matrix (ECM) and human umbilical vein endothelial cells (HUVECs). Almost all lines expressed the beta 1 subunit and approximately half of the lines expressed the beta 4 subunit; by contrast, none expressed the beta 2 subunit. Subunits alpha 2, alpha 3, alpha 5 and alpha 6 were frequently expressed, whereas very few lines expressed alpha 1 and alpha 4. Most lines adhered strongly to ECM (type I collagen, laminin and fibronectin) in correspondence to their expression of integrins. Binding by most lines to fibronectin was completely inhibited by arginine-glycine-aspartic acid (RGD) peptide. Three lines that expressed few or no integrins had very weak ability to adhere to ECM. Strong binding to HUVECs was found in most lines, but the three lines had very little ability to adhere to HUVECs. Binding to HUVECs was strongly inhibited at 4 degrees C, under divalent cation-free conditions and by antibodies to the beta 1 subunit. These results suggest that lung cancer cells adhere to ECM and endothelial cells through integrins, especially the beta 1 subfamily.

Full text

PDF
466

Images in this article

470Figure 4
on p.470

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albelda S. M., Buck C. A. Integrins and other cell adhesion molecules. FASEB J. 1990 Aug;4(11):2868–2880. [PubMed] [Google Scholar]
  2. Ball E. D., Sorenson G. D., Pettengill O. S. Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by gamma-interferon. Cancer Res. 1986 May;46(5):2335–2339. [PubMed] [Google Scholar]
  3. Bunn P. A., Jr, Linnoila I., Minna J. D., Carney D., Gazdar A. F. Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express the Leu-7 antigenic determinant present on natural killer cells. Blood. 1985 Mar;65(3):764–768. [PubMed] [Google Scholar]
  4. Cagliero E., Roth T., Roy S., Lorenzi M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes. 1991 Jan;40(1):102–110. doi: 10.2337/diab.40.1.102. [DOI] [PubMed] [Google Scholar]
  5. Cairncross J. G., Mattes M. J., Beresford H. R., Albino A. P., Houghton A. N., Lloyd K. O., Old L. J. Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5641–5645. doi: 10.1073/pnas.79.18.5641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chammas R., Brentani R. Integrins and metastases: an overview. Tumour Biol. 1991;12(6):309–320. doi: 10.1159/000217732. [DOI] [PubMed] [Google Scholar]
  7. Chan B. M., Matsuura N., Takada Y., Zetter B. R., Hemler M. E. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science. 1991 Mar 29;251(5001):1600–1602. doi: 10.1126/science.2011740. [DOI] [PubMed] [Google Scholar]
  8. Chen F. A., Repasky E. A., Bankert R. B. Human lung tumor-associated antigen identified as an extracellular matrix adhesion molecule. J Exp Med. 1991 May 1;173(5):1111–1119. doi: 10.1084/jem.173.5.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Damjanovich L., Albelda S. M., Mette S. A., Buck C. A. Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am J Respir Cell Mol Biol. 1992 Feb;6(2):197–206. doi: 10.1165/ajrcmb/6.2.197. [DOI] [PubMed] [Google Scholar]
  10. Davis L. S., Oppenheimer-Marks N., Bednarczyk J. L., McIntyre B. W., Lipsky P. E. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol. 1990 Aug 1;145(3):785–793. [PubMed] [Google Scholar]
  11. De Strooper B., Van der Schueren B., Jaspers M., Saison M., Spaepen M., Van Leuven F., Van den Berghe H., Cassiman J. J. Distribution of the beta 1 subgroup of the integrins in human cells and tissues. J Histochem Cytochem. 1989 Mar;37(3):299–307. doi: 10.1177/37.3.2645360. [DOI] [PubMed] [Google Scholar]
  12. Dedhar S., Jewell K., Rojiani M., Gray V. The receptor for the basement membrane glycoprotein entactin is the integrin alpha 3/beta 1. J Biol Chem. 1992 Sep 15;267(26):18908–18914. [PubMed] [Google Scholar]
  13. Dedhar S., Saulnier R. Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes. J Cell Biol. 1990 Feb;110(2):481–489. doi: 10.1083/jcb.110.2.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dransfield I., Hogg N. Regulated expression of Mg2+ binding epitope on leukocyte integrin alpha subunits. EMBO J. 1989 Dec 1;8(12):3759–3765. doi: 10.1002/j.1460-2075.1989.tb08552.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Favrot M. C., Combaret V., Goillot E., Lutz P., Frappaz D., Thiesse P., Thyss A., Dolbeau D., Bouffet E., Tabone E. Expression of integrin receptors on 45 clinical neuroblastoma specimens. Int J Cancer. 1991 Sep 30;49(3):347–355. doi: 10.1002/ijc.2910490306. [DOI] [PubMed] [Google Scholar]
  16. Feldman L. E., Shin K. C., Natale R. B., Todd R. F., 3rd Beta 1 integrin expression on human small cell lung cancer cells. Cancer Res. 1991 Feb 15;51(4):1065–1070. [PubMed] [Google Scholar]
  17. Fradet Y., Cordon-Cardo C., Thomson T., Daly M. E., Whitmore W. F., Jr, Lloyd K. O., Melamed M. R., Old L. J. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1984 Jan;81(1):224–228. doi: 10.1073/pnas.81.1.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harada F., Hirose Y., Tanaka M., Sasaki T., Kamiya H., Miura K. A simple, general method for detecting retroviral RNAs expressed in cells. Jpn J Cancer Res. 1990 Mar;81(3):232–237. doi: 10.1111/j.1349-7006.1990.tb02555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hemler M. E., Elices M. J., Chan B. M., Zetter B., Matsuura N., Takada Y. Multiple ligand binding functions for VLA-2 (alpha 2 beta 1) and VLA-3 (alpha 3 beta 1) in the integrin family. Cell Differ Dev. 1990 Dec 2;32(3):229–238. doi: 10.1016/0922-3371(90)90035-u. [DOI] [PubMed] [Google Scholar]
  20. Hemler M. E., Huang C., Takada Y., Schwarz L., Strominger J. L., Clabby M. L. Characterization of the cell surface heterodimer VLA-4 and related peptides. J Biol Chem. 1987 Aug 25;262(24):11478–11485. [PubMed] [Google Scholar]
  21. Hemler M. E., Sanchez-Madrid F., Flotte T. J., Krensky A. M., Burakoff S. J., Bhan A. K., Springer T. A., Strominger J. L. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol. 1984 Jun;132(6):3011–3018. [PubMed] [Google Scholar]
  22. Hemler M. E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol. 1990;8:365–400. doi: 10.1146/annurev.iy.08.040190.002053. [DOI] [PubMed] [Google Scholar]
  23. Humphries M. J., Olden K., Yamada K. M. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science. 1986 Jul 25;233(4762):467–470. doi: 10.1126/science.3726541. [DOI] [PubMed] [Google Scholar]
  24. Hynes R. O. Integrins: a family of cell surface receptors. Cell. 1987 Feb 27;48(4):549–554. doi: 10.1016/0092-8674(87)90233-9. [DOI] [PubMed] [Google Scholar]
  25. Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992 Apr 3;69(1):11–25. doi: 10.1016/0092-8674(92)90115-s. [DOI] [PubMed] [Google Scholar]
  26. Imanishi K., Yamaguchi K., Suzuki M., Honda S., Yanaihara N., Abe K. Production of transforming growth factor-alpha in human tumour cell lines. Br J Cancer. 1989 May;59(5):761–765. doi: 10.1038/bjc.1989.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Inoue Y., Shijubo N., Uede T. Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients. Jpn J Cancer Res. 1990 Oct;81(10):1012–1020. doi: 10.1111/j.1349-7006.1990.tb03339.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kawaguchi S., Kikuchi K., Ishii S., Takada Y., Kobayashi S., Uede T. VLA-4 molecules on tumor cells initiate an adhesive interaction with VCAM-1 molecules on endothelial cell surface. Jpn J Cancer Res. 1992 Dec;83(12):1304–1316. doi: 10.1111/j.1349-7006.1992.tb02763.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kennel S. J., Foote L. J., Flynn K. M. Tumor antigen on benign adenomas and on murine lung carcinomas quantitated by a two-site monoclonal antibody assay. Cancer Res. 1986 Feb;46(2):707–712. [PubMed] [Google Scholar]
  30. Koizumi M., Uede T., Shijubo N., Kudo R., Hashimoto M., Kikuchi K. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential. Cancer Res. 1988 Nov 15;48(22):6565–6572. [PubMed] [Google Scholar]
  31. Kramer R. H., Vu M., Cheng Y. F., Ramos D. M. Integrin expression in malignant melanoma. Cancer Metastasis Rev. 1991 May;10(1):49–59. doi: 10.1007/BF00046843. [DOI] [PubMed] [Google Scholar]
  32. Lampugnani M. G., Resnati M., Dejana E., Marchisio P. C. The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol. 1991 Feb;112(3):479–490. doi: 10.1083/jcb.112.3.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lauri D., Martin-Padura I., Biondelli T., Rossi G., Bernasconi S., Giavazzi R., Passerini F., Van Hinsbergh V., Dejana E. Role of beta 1 integrins in tumor cell adhesion to cultured human endothelial cells. Lab Invest. 1991 Nov;65(5):525–531. [PubMed] [Google Scholar]
  34. Lieber M., Smith B., Szakal A., Nelson-Rees W., Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976 Jan 15;17(1):62–70. doi: 10.1002/ijc.2910170110. [DOI] [PubMed] [Google Scholar]
  35. Makgoba M. W., Sanders M. E., Ginther Luce G. E., Dustin M. L., Springer T. A., Clark E. A., Mannoni P., Shaw S. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature. 1988 Jan 7;331(6151):86–88. doi: 10.1038/331086a0. [DOI] [PubMed] [Google Scholar]
  36. Mariani Costantini R., Falcioni R., Battista P., Zupi G., Kennel S. J., Colasante A., Venturo I., Curio C. G., Sacchi A. Integrin (alpha 6/beta 4) expression in human lung cancer as monitored by specific monoclonal antibodies. Cancer Res. 1990 Sep 15;50(18):6107–6112. [PubMed] [Google Scholar]
  37. Martìn-Padura I., Mortarini R., Lauri D., Bernasconi S., Sanchez-Madrid F., Parmiani G., Mantovani A., Anichini A., Dejana E. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res. 1991 Apr 15;51(8):2239–2241. [PubMed] [Google Scholar]
  38. Mette S. A., Pilewski J., Buck C. A., Albelda S. M. Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo. Am J Respir Cell Mol Biol. 1993 May;8(5):562–572. doi: 10.1165/ajrcmb/8.5.562. [DOI] [PubMed] [Google Scholar]
  39. Miyake K., Hasunuma Y., Yagita H., Kimoto M. Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture. J Cell Biol. 1992 Nov;119(3):653–662. doi: 10.1083/jcb.119.3.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nicolson G. L. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev. 1988 Jun;7(2):143–188. doi: 10.1007/BF00046483. [DOI] [PubMed] [Google Scholar]
  41. Perrotti D., Cimino L., Falcioni R., Tibursi G., Gentileschi M. P., Sacchi A. Metastatic phenotype: growth factor dependence and integrin expression. Anticancer Res. 1990 Nov-Dec;10(6):1587–1597. [PubMed] [Google Scholar]
  42. Pischel K. D., Hemler M. E., Huang C., Bluestein H. G., Woods V. L., Jr Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2. J Immunol. 1987 Jan 1;138(1):226–233. [PubMed] [Google Scholar]
  43. Ruff M. R., Pert C. B. Small cell carcinoma of the lung: macrophage-specific antigens suggest hemopoietic stem cell origin. Science. 1984 Sep 7;225(4666):1034–1036. doi: 10.1126/science.6089338. [DOI] [PubMed] [Google Scholar]
  44. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem. 1988;57:375–413. doi: 10.1146/annurev.bi.57.070188.002111. [DOI] [PubMed] [Google Scholar]
  45. Ruoslahti E., Pierschbacher M. D. New perspectives in cell adhesion: RGD and integrins. Science. 1987 Oct 23;238(4826):491–497. doi: 10.1126/science.2821619. [DOI] [PubMed] [Google Scholar]
  46. Sonnenberg A., Daams H., Van der Valk M. A., Hilkens J., Hilgers J. Development of mouse mammary gland: identification of stages in differentiation of luminal and myoepithelial cells using monoclonal antibodies and polyvalent antiserum against keratin. J Histochem Cytochem. 1986 Aug;34(8):1037–1046. doi: 10.1177/34.8.2426332. [DOI] [PubMed] [Google Scholar]
  47. Springer T. A., Dustin M. L., Kishimoto T. K., Marlin S. D. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol. 1987;5:223–252. doi: 10.1146/annurev.iy.05.040187.001255. [DOI] [PubMed] [Google Scholar]
  48. Staatz W. D., Rajpara S. M., Wayner E. A., Carter W. G., Santoro S. A. The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen. J Cell Biol. 1989 May;108(5):1917–1924. doi: 10.1083/jcb.108.5.1917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Suzuki S., Takahashi T., Nakamura S., Koike K., Ariyoshi Y., Takahashi T., Ueda R. Alterations of integrin expression in human lung cancer. Jpn J Cancer Res. 1993 Feb;84(2):168–174. doi: 10.1111/j.1349-7006.1993.tb02851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Terasaki T., Shimosato Y., Nakajima T., Tsumuraya M., Morinaga S., Hirohashi S., Yamaguchi K., Kato K., Ichinose H., Nagatsu T. Changes in cell characteristics due to culture conditions in cell lines from human small cell lung cancer. Jpn J Clin Oncol. 1986 Sep;16(3):203–212. [PubMed] [Google Scholar]
  51. Walz G., Aruffo A., Kolanus W., Bevilacqua M., Seed B. Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science. 1990 Nov 23;250(4984):1132–1135. doi: 10.1126/science.1701275. [DOI] [PubMed] [Google Scholar]
  52. Werb Z., Tremble P. M., Behrendtsen O., Crowley E., Damsky C. H. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol. 1989 Aug;109(2):877–889. doi: 10.1083/jcb.109.2.877. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES